Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer
NCT01654367
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Zoledronic Acid and Aromatase Inhibitors
Sponsor
Tianjin Medical University